ERK2 stimulates MYC transcription by anchoring CDK9 to the MYC promoter in a kinase activity–independent manner
Science Signaling · 2023
DOI: 10.1126/scisignal.adg4193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2023. Verfasst von Lorena Agudo-Ibáñez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Cantabria, Sant…. Hauptthemen laut MEDLINE: RNA Polymerase II, Transcription Factors. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
The transcription factor MYC regulates cell proliferation, transformation, and survival in response to growth factor signaling that is mediated in part by the kinase activity of ERK2. Because ERK2 can also bind to DNA to modify gene expression, we investigated whether it more directly regulates MYC transcription. We identified ERK2 binding sites in the MYC promoter and detected ERK2 at the promoter in various serum-stimulated cell types. Expression of nuclear-localized ERK2 constructs in serum-starved cells revealed that ERK2 in the nucleus—regardless of its kinase activity—increased MYC mRNA expression and MYC protein abundance. ERK2 bound to the promoter through its amino-terminal insert domain and to the cyclin-dependent kinase CDK9 (which activates RNA polymerase II) through its carboxyl-terminal conserved docking domain. Both interactions were essential for ERK2-induced MYC expression, and depleting ERK impaired CDK9 occupancy and RNA polymerase II progression at the MYC promoter. Artificially tethering CDK9 to the MYC promoter by fusing it to the ERK2 insert domain was sufficient to stimulate MYC expression in serum-starved cells. Our findings demonstrate a role for ERK2 at the MYC promoter acting as a kinase-independent anchor for the recruitment of CDK9 to promote MYC expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Cantabria, Santander 39011, Spain.
- Instituto de Investigaciones Biomédicas "Alberto Sols," Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid 28029, Spain.
- Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid 2809, Spain.
ORCID-Profile: Lorena Agudo-Ibáñez, Marta Morante, Lucía García-Gutiérrez, Javier Rodríguez, Alberto Muñoz, Javier León, Piero Crespo
Zitieren
APA
Agudo-Ibáñez, L., Morante, M., García-Gutiérrez, L., Quintanilla, A., Rodríguez, J., Muñoz, A., León, J., & Crespo, P. (2023). ERK2 stimulates MYC transcription by anchoring CDK9 to the MYC promoter in a kinase activity–independent manner. Science Signaling. https://doi.org/10.1126/scisignal.adg4193
Vancouver
Agudo-Ibáñez L, Morante M, García-Gutiérrez L, Quintanilla A, Rodríguez J, Muñoz A, et al. ERK2 stimulates MYC transcription by anchoring CDK9 to the MYC promoter in a kinase activity–independent manner. Science Signaling. 2023. doi:10.1126/scisignal.adg4193
BibTeX
@article{AgudoIbez2023,
author = {Agudo-Ibáñez, Lorena and Morante, Marta and García-Gutiérrez, Lucía and Quintanilla, Andrea and Rodríguez, Javier and Muñoz, Alberto and León, Javier and Crespo, Piero},
title = {ERK2 stimulates MYC transcription by anchoring CDK9 to the MYC promoter in a kinase activity–independent manner},
journal = {Science Signaling},
year = {2023},
doi = {10.1126/scisignal.adg4193}
}
EUVIMED